Intraductal Cancer of the Prostate (IDC-P): Diagnosis and Characterization
A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Cancer Causes, Screening and Diagnosis".
Deadline for manuscript submissions: closed (30 June 2024) | Viewed by 11552
Special Issue Editor
Special Issue Information
Dear Colleagues,
IDC-P is complicated to recognize; it is considered an intra-acinar and/or intraductal neoplastic epithelial proliferation that exhibits more important architectural and/or cytologic atypia than high-grade prostatic intraepithelial neoplasia (PIN). It is considered a distinct entity in the 2016 WHO classification of tumors of the prostate, and occupies an important chapter in the new WHO 2022 classification.
Pathologists now have a better knowledge of the IDC-P, and this entity has also started to make its way toward clinicians. Nevertheless, much research and teaching still have to be undertaken in order to recognize and report this type of tumor in the correct way. Recognizing IDC-P can be extremely challenging, and in cases of no invasive tumor, it is of major interest to recognize IDC-P. Recommendations are therefore that IDC-P should be reported in prostatectomies and especially in prostate biopsies if no invasive prostate cancer is seen, and it is important to perform basal cell immunostains on biopsy and RP to identify IDC-P.
According to GUPS, IDC-P should not be included in determining the final Gleason score/grade group on prostate biopsies and/or RP.
Several studies have shown that ICD-P has a negative impact on the patient’s outcome, and that these lesions must be reported in the pathology report, as it is not recommended to include patients with IDC-P in active surveillance programs.
Prof. Dr. Eva M. Comperat
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- atypical aspects of IDC-P
- prognosis
- diagnosis
- recommendations
- treatment
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue policies can be found here.